eSUNMed is committed to the development of biomedical materials.
The main business of eSUNMed includes biomedical monomers (caprolactone CL, etc.), biomedical polymers (L-polylactic acid PLLA, etc.),
Medical 3D printing materials (implantation grade peek, etc.) and medical processing services (polycaprolactone microspheres PCL, etc.). Please feel free to inquire!

about
eSUNMed

eSUNMed experts in the field of biomedical materials, integrating R&D, production and sales. eSUNMed is located in Longhua District, Shenzhen. The main base covers an area of more than 2,000 square meters. It has a 100,000-level clean workshop and a 10,000-level purification laboratory.

eSUNMed has developed the industrialization technology of polylactic acid and polycaprolactone and has complete process experience in the industrialization of esters. eSUNMed’s products include biomedical monomers (caprolactone CL, lactide LA), biomedical polymers (L-polylactic acid PLLA, D-polylactide PDLA, etc.), medical 3D printing materials (implantable peek, pla, etc.) and medical processing services (polycaprolactone microspheres PCL, polylactic acid microspheres PLA, etc.).

news and information

news_img

eSUNMED PDLLA Materials and Applications.

  Poly(D, L-lactide),PDLLA Racemic polylactic acid (Poly(D,L-lactide), PDLLA) is an amorphous polymer composed of both left-handed (L-type) and right-handed (D-type) isomers, possessing unique physical and chemical properties, as well as excellent biocompatibility and degrad...

View Details
news_img

eSUNMED Obtains Patent Authorization for “A Medical Biodegradable Microsphere and Its Preparation Process”!

On May 31, 2024, the “A Medical Biodegradable Microsphere and Its Preparation Process”, independently developed by Shenzhen Esun Industrial Co., Ltd. and its subsidiary eSUNMed Biotechnology (Shenzhen)Co.,Ltd., was officially approved by the National Intellectual Property Administr...

View Details
news_img

eSUNMED ‘s Poly-L-lactic acid (PLLA) has passed the National Medical Products Administration’s main document registration

Congratulations to eSUNMED for the successful registration of their Poly-L-lactic acid (PLLA) material with the National Medical Products Administration’s main medical device document on May 11, 2024. The main document registration number is M2024152-000. This is another registered product ...

View Details
news_img

Explore the new era of medical aesthetics! On April 25-26, eSUNMED invites you to meet at the IHMD·2024 International High-end Medical Device Summit

On April 25-26, the IHMD·2024 International High-end Medical Device Summit will be held at the Longemont Shanghai Hotel. eSUNMED, a biomedical brand created by eSUNMed Biotechnology (Shenzhen)Co., Ltd., is dedicated to the synthesis, modification, and application of biomedical polymers, as well ...

View Details
news_img

Closure of the 2024 Medical Polymer Conference: eSUNMed Welcomes all Friends for Consultation and Collaboration!

On March 28-29, the Medical Polymer Products Professional Committee of the China Association for Medical Devices Industry grandly held its 2024 annual meeting. Experts and scholars from the medical device field across various regions and representatives from enterprises and institutions gathered ...

View Details